ResMed Inc. vs Taskus Inc — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: ResMed Inc. is far larger — about 54.1× Taskus Inc's market cap, and ResMed Inc. pays a 1.21% dividend while Taskus Inc pays none. Which is the better fit depends on your goals.
| RMD | TASK | |
|---|---|---|
Market Cap | $28.81B | $532.07M |
Sector | Health | Technology |
52-Week High | $293.73 | $18.21 |
52-Week Low | $182.82 | $4.57 |
Enterprise Value | $27.99B | $927.77M |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →